121 – 130 of 144
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Impact of community pharmaceutical care on patient health and quality of drug treatment in Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Intrajejunal Levodopa Versus Conventional Therapy in Parkinson Disease: Motor and Nonmotor Effects.
(
- Contribution to journal › Article
-
Mark
Duration of L-dopa and dopamine agonist monotherapy in Parkinson´s disease
(
- Contribution to journal › Article
-
Mark
Gender-related differences in the burden of non-motor symptoms in Parkinson's disease
(
- Contribution to journal › Article
- 2011
-
Mark
Levodopa--carbidopa intestinal gel for treatment of advanced Parkinson''s disease
(
- Contribution to journal › Scientific review
-
Mark
What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus?
(
- Contribution to journal › Article
-
Mark
Wirkung von Apomorphin auf nicht motorische Symptome bei Morbus Parkinson
(
- Contribution to journal › Scientific review
-
Mark
Current Options and Future Possibilities for the Treatment of Dyskinesia and Motor Fluctuations in Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
Apomorphininjektionstherapie bei Morbus Parkinson
(
- Contribution to journal › Scientific review
-
Mark
Drug-related problems in Parkinson's disease: the role of community pharmacists in primary care
(
- Contribution to journal › Article